POZ: "The combination of Norvir (ritonavir)–boosted Invirase (saquinavir) may be associated with a life-threatening side effect on the heart, according to new changes to Invirase’s prescribing information announced by the FDA on Thursday, October 21, and reported by PR Newswire. The prescribing information changes follow a preliminary announcement in February describing a potential link between Norvir/Invirase and heart rhythm disturbances."
0 comments:
Post a Comment